WILMINGTON, DE / ACCESSWIRE / November 17, 2022 / Transparency Market Research Inc. - In 2021, the value of the global non-invasive cancer diagnostics market stood at US$ 104.8 Bn. It is predicted that the global market will develop at 7% CAGR during the forecast period, from 2022 to 2031. It is anticipated that by 2031, the worth of the global non-invasive cancer diagnostics market will surpass a valuation of US$ 207 Bn. Over the past few years, there has been an improvement in cancer prevention initiatives and early identification, which has decreased death rates. Making sure that patients are diagnosed, treated, and reported quickly is necessary for early diagnosis. The global non-invasive cancer diagnostics market growth is anticipated to be driven by improvements in molecular techniques, contrast agents, sensors, and Artificial Intelligence (AI) that help in the real-time detection of cancer-specific signals.

In order to lessen the financial and social costs of cancer, risk-based diagnosis and prevention must be available to everybody. In near future, the global market is projected to grow as a result of improving detection accuracy with a practical strategy made possible by non-invasive cancer diagnostic techniques. Leading players in non-invasive cancer diagnostics are heavily investing in developing better non-invasive cancer diagnostics.

Get an Exclusive PDF Sample Copy of the Non-Invasive Cancer Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8197

Key Findings of Market Report

• The development of imaging equipment, cancer cases, the rising number of elderly people, and the demand for non-invasive cancer detection methods are all expected to drive the global market. The geriatric population is much more likely to develop chronic illnesses like cancer, which increases the demand for cancer diagnostics. The future market demand for non-invasive cancer diagnostics is thus predicted to grow as a result.

• Based on test type, the category of imaging test accounted for the most market share for non-invasive cancer diagnostics globally. Since patients are increasingly favoring imaging tests, the trend is anticipated to last throughout the projection period. For cancer diagnosis and progression monitoring, an increasing percentage of cancer patients choose painless imaging examinations, which is one of the recent developments in the non-invasive cancer diagnostics market.

• In terms of cancer type, in 2021, the breast cancer category commanded a sizeable market share globally. This can be attributed to the global rise in breast cancer cases and the expansion of women's populace between the ages of 50 and 74. In the upcoming years, the category is expected to grow due to rising efforts by various agencies for breast cancer early detection and diagnosis.

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=8197

Global Non-Invasive Cancer Diagnostics Market: Growth Drivers

• Depending on the end-user, in 2021 the hospitals & clinics category represented the largest share of the global market. This is explained by rising non-invasive cancer diagnostic methods and the expansion of hospitals. There are now more hospitals, which has resulted in a rise in the volume of cancer detection tests done.

• A large chunk of the global non-invasive cancer diagnostics market in 2021 was held by North America, per the report. This is explained by the rise in cancer cases, shifting demographics, evolving lifestyles, as well as the existence of advanced point-of-care diagnostic facilities in both Canada and the US. The region is the fastest-growing market for non-invasive cancer diagnostics market.

Global Non-Invasive Cancer Diagnostics Market: Key Players

Some of the key market players are

• Sonic Healthcare Limited

• The University of Texas MD Anderson Cancer Center

• RadNet Management, Inc.

• Dr. Lal PathLabs Ltd.

• Memorial Sloan Kettering Cancer Center

• Beverly Hills Cancer Center

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=8197

Global Non-Invasive Cancer Diagnostics Market: Segmentation

Test Type

• Urine Test

• Imaging Test

• Spectroscopy

Cancer Type

• Breast Cancer

• Lung Cancer

• Blood Cancer

• Ovarian Cancer

• Colorectal Cancer

• Others

End User

• Hospitals & Clinics

• Ambulatory Care

• Others

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Cancer Diagnostics Market: The global cancer diagnostics market is anticipated to reach more than US$ 335.7 Bn by the end of 2031 at a CAGR of 7.4% from 2022 to 2031.

Diagnostic Reagents Market: The global diagnostic reagents market is anticipated to reach more than US$ 85.8 Bn by the end of 2031 at a CAGR of 6.5% from 2022 to 2031.

Central Lab Market: The global central lab market is expected to reach the value of US$ 4 Bn by the end of 2031 at a CAGR of 5.4% from 2021 to 2031.

Preeclampsia Diagnostics Market: It is projected to grow at a CAGR of 3.8% and reach US$ 2.3 Bn by the end of 2031at a CAGR of 3.8% by the end of 2031.

Cervical Cancer Diagnostic Tests Market: The global cervical cancer diagnostic tests market is expected to exceed a hasvalue of US$ 13.6 Bn by the end of 2031 at a CAGR of 4.6% from 2022 to 2031.

Diagnostic Imaging Services Market: The global diagnostic imaging services market is anticipated to be valued at more than US$ 544.7 Bn by the end of 2031 at a CAGR of 4.1% from 2022 to 2031.

Neurovascular Catheters Market: The global neurovascular catheter market is anticipated to be valued near around US$ 7.5 Bn by the end of 2032 at a CAGR of 7.9% from 2022 to 2032.

ASRs and RUOs Market: The U.S. ASRs and RUOs market is expected to surpass the value of US$ 5.3 Bn by the end of 2031 at a CAGR of 4.7% from 2021 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyse information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

SOURCE: Transparency Market Research inc.

View source version on accesswire.com:
https://www.accesswire.com/726543/Non-Invasive-Cancer-Diagnostics-Market-to-Rise-at-a-CAGR-of-7-during-Forecast-Period-notes-TMR-Study